Jennifer Cassels
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 8
- Acute Myeloid Leukemia Research 3
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 8
- Mesenchymal stem cell research 2
-
- HER2/EGFR in Cancer Research 2
- Cancer-related Molecular Pathways 2
-
- Ubiquitin and proteasome pathways 2
- PI3K/AKT/mTOR signaling in cancer 2
- Co-authors
- Tessa L. HolyoakeKaren DunnDavid VetriePaolo GallipoliFrancesca PellicanoHeather G. JørgensenKoorosh KorfiLisa Hopcroft
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- United KingdomGermanyEgypt
In The Last Decade
Jennifer Cassels
15 papers receiving 250 citations
Peers
Comparison fields: 5 of 33
- Hematology 166
- Genetics 94
- Rheumatology 39
- Immunology 42
- Oncology 43
Countries citing papers authored by Jennifer Cassels
This map shows the geographic impact of Jennifer Cassels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Cassels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Cassels more than expected).
Fields of papers citing papers by Jennifer Cassels
This network shows the impact of papers produced by Jennifer Cassels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Cassels. The network helps show where Jennifer Cassels may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jennifer Cassels, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 3 | |
| 7 | 2020 | 1 | |
| 8 | 2020 | 50 | |
| 9 | 2019 | 7 | |
| 10 | 2019 | 1 | |
| 11 | 2019 | 1 | |
| 12 | 2016 | 99 | |
| 13 | 2016 | 56 | |
| 14 | 2016 | 1 | |
| 15 | 2015 | 10 | |
| 16 | 2013 | 0 | |
| 17 | 1966 | 1 |
About Jennifer Cassels
Jennifer Cassels is a scholar working on Genetics, Hematology and Oncology, having authored 17 papers that have together received 250 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (8 papers), Acute Myeloid Leukemia Research (3 papers), Mesenchymal stem cell research (2 papers), Ubiquitin and proteasome pathways (2 papers), HER2/EGFR in Cancer Research (2 papers), Cancer-related Molecular Pathways (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Hematology (166 citations), Genetics (94 citations) and Rheumatology (39 citations). Jennifer Cassels has collaborated with scholars based in United Kingdom, Germany and Egypt. Frequent co-authors include Tessa L. Holyoake, Karen Dunn, David Vetrie, Paolo Gallipoli, Francesca Pellicano, Heather G. Jørgensen, Koorosh Korfi, Lisa Hopcroft, Ross Kinstrie and Mary T. Scott. Their work appears in journals such as Nature Communications, Blood and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.